The Avicanna Advantage
Avicanna™ is positioned to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and Extracts throughout North America, Latin America, Europe and Asia.
Scientific and Evidence-Based
Avicanna‘s team of scientists and researchers develop plant-derived cannabinoid formulations for medical applications and consumer products. This scientific and evidence-based approach has enabled Avicanna™ to offer portfolios of cannabinoid-based solutions for a range of channels and markets including derma-cosmetics, phyto-therapeutics and pharmaceutical products.
Organic and Sustainable Supply Chain
In 2018, we acquired a controlling interest in two companies in Colombia focused on commercial cannabis activities. Both companies are located in Santa Marta, Colombia in the foothills of the Sierra Nevada mountains. The location offers 12 hours of daily sunlight year round, while the tropical weather of Santa Marta and micro-climate of the Sierra Nevada mountains provide optimal conditions to maximize the number and amount of harvests. Access to cost efficient energy sources and construction labour allow for affordable expansion and production. Both companies also have easy access to the local Santa Marta shipping port which is expected to provide low cost shipping for export.
Our two Colombian cultivation subsidiaries focus on cultivating high yielding THC and CBD plants as well as the production of cannabis extracts and purified cannabinoids to be made available for wholesale distribution. We have several export targets for wholesale distribution, and are developing key relationships within the European Union, Mexico and Chile.
Santa Marta Golden Hemp S.A.S. ("Aurum")
*Aurum is Santa Marta Golden Hemp S.A.S.
Our research and development and cultivation activities are focused on the development of our products, which will include plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and cannabis extracts and purified cannabinoids. We are preparing for some of our products to be available in several markets in the upcoming year.
Cannabis has been used in natural therapies for many years and by many cultures worldwide; we use the information gained from historical records as part of our understanding for how cannabinoids can be used to target various physical conditions, therapeutic areas and diseases. Our concept discovery process includes the review and analysis of anecdotal data collected from external sources such as online publications and information regarding past and present use in various international markets. Internal data collection and data sharing from our relationships with healthcare professionals assist in our product and clinical development. These concepts are tested through our R&D activities and further realized and enhanced by our strategic relationships with universities and medical establishments.